Discriminative-Stimulus Effects of Triazolam in Women and Men

REFERENCES

• Lynch LJ, Roth ME, Carroll ME. Biological basis of sex differences in drug abuse: Preclinical and clinical studies. Psychopharmacology 2002; 164:121–137.
   PubMed Web of Science ®Google Scholar
• Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove, KP. Sex and estrogen influence drug abuse. Trends Pharmacol Sci 2004; 25(5):273–279.
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L. The use of abusable prescription drugs: The role of gender. J Womens Health Gend Based Med 2000; 9(3):289–297.
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. Preliminary findings from the 2002 National Household Survey on Drug Abuse. Retrieved June 10, 2004 from www.samhsa.gov.
   Google Scholar
• Simoni-Wastila L. Gender and psychotropic drug use. Med Care 1998; 36(1):88–94.
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004; 39(1):1–23.
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. Am J Pub Health 2004; 94(2):266–268.
   PubMed Web of Science ®Google Scholar
• Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994; 48(1):25–40.
   Google Scholar
• Rickels K. The clinical use of hypnotics: Indications for use and the need for a variety of hypnotics. Acta Psychiatr Scand Suppl 1986; 332:132–141.
   PubMedGoogle Scholar
• Van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ 1993; 307:363–366.
   PubMed Web of Science ®Google Scholar
• Swartz M, Landerman R, George LK, Melville ML, Blazer D, Smith K. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. Am J Pub Health 1991; 81(5):592–596.
   PubMed Web of Science ®Google Scholar
• Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch of Intern Med 1994; 154:1235–1240.
   PubMedGoogle Scholar
• Des las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: More behavioral addiction than dependence. Psychopharmacology 2003; 167:297–303.
   PubMedGoogle Scholar
• Greenblatt DJ, Harmatz JS, Von Moltke LL, Wright CE, Durol ALB, Harrell-Joseph LM, Shader RI. Comparative kinetics and response to benzodiazepine agonists triazolam and zolpidem: Evaluation of sex-dependent differences. J Psychopharmacol Exp Ther 2000; 293(2):435–443.
   PubMedGoogle Scholar
• Rukstalis M, De Wit H. Effects of triazolam at three phases of the menstrual cycle. J Clin Psychopharmacol 1999; 19(5):450–458.
   PubMedGoogle Scholar
• Kamimori GH, Sirisuth N, Greenblatt DJ, Eddington ND. The influence of the menstrual cycle on triazolam and indocyanine green pharmacokinetics. J Clin Pharmacol 2000; 40:739–744.
   PubMedGoogle Scholar
• Rush CR, Baker RW, Rowlett JK. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacol 2000; 8:22–36.
   PubMed Web of Science ®Google Scholar
• Rush CR, Griffiths RR. Zopidem, triazolam, temazepam: Beahvioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 1996; 16(2):146–157.
   PubMedGoogle Scholar
• Kollins SH, Rush CR. Effects of training dose on the relationship between the discriminative-stimulus and self-reported effects of d-amphetamine in humans. Pharmacol Biochem Behav 1996; 64:319–326.
   Google Scholar
• Rush CR, Madakasira S, Goldman NH, Woolverton W, Rowlett JK. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 1997; 280:174–188.
   PubMedGoogle Scholar
• Jasinski DR. Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Handbook of Experimental Pharmacology. Martin WR, ed. Berlin: Springer, 1977; 197–258.
   Google Scholar
• Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiological, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12:245–258.
   PubMed Web of Science ®Google Scholar
• Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychopharmacology 1973; 10(4):431–436.
   Google Scholar
• Evans SM, Funderburk FR, Griffiths RR. Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990; 255:1246–1255.
   PubMed Web of Science ®Google Scholar
• Mumford GK, Evans SM, Fleishaker JC, Griffiths RR. Alprazolam absorption kinetics affects abuse liability. Clin Pharmacol Ther 1995; 57:356–365.
   PubMed Web of Science ®Google Scholar
• Mumford GK, Rush CR, Griffiths RR. Abecarnil and alprazolam in humans: Behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 1995; 272:570–580.
   PubMed Web of Science ®Google Scholar
• McLeod DR, Griffiths RR, Bigelow GE, Yingling JE. An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instrum 1982; 14:463–466.
   Google Scholar
• Griffiths RR, Bigelow GE, Liebson I. Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 1983; 40:865–873.
   PubMed Web of Science ®Google Scholar
• Abreu ME, Griffiths RR. Drug tasting may confound human drug discrimination studies. Psychopharmacology 1996; 125:255–257.
   PubMedGoogle Scholar
• Saladin ME, Brady KT, Dansky BS, Kilpatrick DG. Understanding comorbidity between PTSD and substance abuse disorders: Two preliminary investigations. Addictive Behav 1995, 20:643–655.
   PubMed Web of Science ®Google Scholar
• Kelly TH, Stoops WW, Perry AS, Prendergast MA, Rush CR. Clinical neuropharmacology of drugs of abuse: A comparison of drug-discrimination and subject-report measures. Behav Cog Neurosci Rev 2003; 2(4):227–260.
   PubMedGoogle Scholar
• Preston KL, Bigelow GE. Subjective and discriminative effects of drugs. Behav Pharmacol 1991; 2:293–313.
   PubMed Web of Science ®Google Scholar
• Rush CR, Kelly TH, Fillmore MT, Hays LR. Discriminative-stimulus effects of triazolam in light and moderate drinkers. Alcohol Clin Exp Res 2003; 27(4):638–646.
   PubMedGoogle Scholar
• Lile JA, Stoops WW, Rush CR. The effect of gender on the discriminative-stimulus and subject-rated effects of d-amphetamine in humans. Problems of drug dependence. College on Problems of Drug Dependence, 64th Annual Scientific Meeting. Abstract available from www.cpdd.vcu.edu. Accessed on June 10, 2004, Bal Harbor, FL.
   Google Scholar
• Zacny JP. Morphine responses in humans: A retrospective analysis of sex differences. Drug Alcohol Depend 2001; 63:23–28.
   PubMed Web of Science ®Google Scholar
• Craft RM, Stratmann JA. Discriminative stimulus effects of cocaine in female versus male rats. Drug Alcohol Depend 1996; 42:27–37.
   PubMedGoogle Scholar
• Anderson KG, van Haaren F. Cocaine discrimination and time-course effects in male and female wistar rats. Eur J Pharmacol 1999; 382:69–74.
   PubMedGoogle Scholar
• Craft RM, Heideman LM, Bartok RE. Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats. Drug Alcohol Depend 1999; 53:95–109.
   PubMedGoogle Scholar
• Cicero TJ, Aylward SC, Meyer ER. Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav 2003; 74:51–549.
   Google Scholar
• Cicero TJ, Ennis T, Ogden J, Meyer ER. Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav 1999; 65(1):91–96.
   Google Scholar
• Tseng AH, Craft RM. Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 2001; 430:41–47.
   PubMed Web of Science ®Google Scholar
• Physician's Desk Reference. Thompson PDR, Montvale, NJ, 2004.
   Google Scholar
• Rush CR, Ali JA. Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans. Behav Pharmacol 1999; 10(4):401–413.
   PubMedGoogle Scholar
• Rush CR, Baker RW. Zolpidem and triazolam interact differentially on a digit-enter-and-recall task. Human Psychopharmacol 2001; 16(2):147–157.
   PubMedGoogle Scholar
• Rush CR, Armstron PL, Ali JA, Pazzaglia PJ. Benzodiazepine-receptor ligands in humans: Acute performance impairment, subject-rated, and observer-rated effects. J Clin Psychopharmacol 1998; 18(2):154–165.
   PubMed Web of Science ®Google Scholar
• Rush CR, Critchfield TS, Troisi JR, Griffiths RR. Discriminative-stimulus effects of diazepam and buspirone in normal volunteers. J Exp Anal Behav 1995; 63(3):277–294.
   PubMedGoogle Scholar